Europe In Vitro Fertilization Market Size & Outlook
Related Markets
Europe in vitro fertilization market highlights
- The Europe in vitro fertilization market generated a revenue of USD 9,304.3 million in 2023.
- The market is expected to grow at a CAGR of 5% from 2024 to 2030.
- In terms of segment, frozen nondonor was the largest revenue generating procedure type in 2023.
- Fresh Donor is the most lucrative procedure type segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 9,304.3 million |
| Market revenue in 2030 | USD 13,051.7 million |
| Growth rate | 5% (CAGR from 2023 to 2030) |
| Largest segment | Frozen nondonor |
| Fastest growing segment | Fresh Donor |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
| Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
Other key industry trends
- In terms of revenue, Europe region accounted for 36.7% of the global in vitro fertilization market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 14,294.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In Vitro Fertilization Market Scope
In Vitro Fertilization Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| US Fertility | View profile | 1001-5000 | Rockville, Maryland, United States, North America | https://www.usfertility.com/ |
| TFP Fertility Group | View profile | 501-1000 | Oxford, Oxfordshire, United Kingdom, Europe | https://tfp-fertility.com/ |
| RMA Network | View profile | 101-250 | Basking Ridge, New Jersey, United States, North America | https://rmanetwork.com/ |
| Fortis Healthcare | View profile | 10001+ | Gurgaon, Haryana, India, Asia | http://fortishealthcare.com |
| Nova IVF | View profile | 11-50 | Mountain View, California, United States, North America | https://www.novaivf.com |
| Ferring | View profile | 5001-10000 | Saint-prex, Vaud, Switzerland, Europe | https://www.ferring.com |
| Cook Medical | View profile | 10001+ | Bloomington, Indiana, United States, North America | http://www.cookmedical.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Genea Biomedx | View profile | 101-250 | Sydney, New South Wales, Australia, Oceania | https://www.geneabiomedx.com |
| The Cooper Companies Inc | View profile | 15000 | 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, United States, 94583 | https://www.coopercos.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| FUJIFILM Holdings Corp | View profile | 83784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | http://www.fujifilmholdings.com |
| Vitrolife AB ADR | View profile | 1116 | Box 9080, Gothenburg, Sweden, 400 92 | https://www.vitrolife.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Europe in vitro fertilization market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Frozen nondonor was the largest segment with a revenue share of 48.34% in 2023. Horizon Databook has segmented the Europe in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
In 2022, Europe emerged as the dominant region in the IVF market, accounting for the largest revenue share. Growth of the IVF market in Europe is being driven by an increase in medical tourism. A rising number of individuals from the U.S. are opting to travel to the Czech Republic to access more affordable IVF treatments.
In addition, individuals who cannot afford to travel to Europe are seeking IVF treatments domestically at approximately one-third of the cost charged by clinics in the U.S. The cost of IVF treatments in the U.S. is estimated to be around USD 25,000, encompassing processes such as fertilization and growth & development of the egg.
Utilizing an egg donor in the IVF process may result in a higher cost, typically around USD 30,000. The affordability and accessibility of IVF treatments abroad have contributed to growth of medical tourism, attracting individuals seeking more affordable options to fulfill their reproductive aspirations.
Reasons to subscribe to Europe in vitro fertilization market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe in vitro fertilization market databook
-
Our clientele includes a mix of in vitro fertilization market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe in vitro fertilization market , including forecasts for subscribers. This continent databook contains high-level insights into Europe in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe in vitro fertilization market size, by country, 2018-2030 (US$M)
Europe In Vitro Fertilization Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
